Pharmaceutical Supply – Meloxicam Tablets

The contract entails the supply of four bottles of FDA-approved Meloxicam Tablets, identified by NDC68382-0051-01, to meet federal and Defense Logistics Agency specifications. These tablets are eligible for medical substitution, ensuring flexibility in dispensing within authorized healthcare settings. The agreement falls under a subcontract category with the North American Industry Classification System code 325412, indicating pharmaceutical manufacturing, and is issued by the Defense Logistics Agency under the Department of Defense. Although specific delivery locations and point of contact details are not provided, the contract was posted on August 5, 2026, and can be referenced via the DIBBS system using the provided contract and delivery identifiers. Compliance with all regulatory and logistical requirements set by federal authorities and the DLA is mandatory for full award fulfillment.